Latest Breaking News On - Oxford university sarah gilbert - Page 8 : comparemela.com

UNDER STRAIN A small-scale, not-peer-reviewed trial by the University of the Witwatersrand, Johannesburg has suggested the Oxford/AstraZeneca vaccine provides only minimal protection against mild-to-moderate infections of the South African COVID-19 variant, which was first identified in mid-November 2020. While The Guardian notes that researchers are still hopeful the drug offers significant protection against more serious infections which were not studied; the “10% efficacy” claim only relates to the mild-moderate cases South Africa has nonetheless halted the vaccine’s roll-out. Pofessor of vaccinology at Oxford University Sarah Gilbert has told the BBC developers are likely to have a modified jab by spring [autumn in the UK] to combat the new variant.

Nay pyi tawBlue mountainsSouth africaAustralian capital territorySouth africanChris bowenLucia osborne crowley meanjinScott morrisonKristina keneallyOxford astrazenecaTroy bramstonJohn barilaroSuu kyiPolice in myanmarUniversity of oxford john cairnsNational australia bank